Aptagel Plasmonic Fiber Optic Biosensor for In Vivo Continuous Drug Monitoring
ACS Sensors · 24.07.2026 · 11 (7) · 5858-5868
DOI: 10.1021/acssensors.6c00681 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 23.06.2026. Verfasst von Pragnya Satapathy und 11 weiteren Autor:innen. Beteiligte Einrichtung: BioMed X Institute, Heidelberg69120, Germany. Hauptthemen laut MEDLINE: Vancomycin, Fiber Optic Technology, Aptamers, Nucleotide, Surface Plasmon Resonance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Boehringer Ingelheim, Ministerstvo Školství, Mládeže a Telovýchovy, Grantová Agentura Ceské Republiky.
Abstract (Originalsprache)
Continuous monitoring of drug dynamics directly in living tissue remains a major challenge, notably in the brain, where the blood−brain barrier creates distinct microenvironments. Here, we report an implantable fiber optic surface plasmon resonance (FO-SPR) biosensor coated with aptagel, a split-aptamer-crosslinked hydrogel, for continuous monitoring of a small-molecule drug, vancomycin. The aptagel undergoes analyte-induced volumetric and refractive index changes, providing a self-contained means for reversible, label-free optical detection via shifts in the SPR wavelength (λSPR) while ensuring sensor stability in complex physiological matrices. The sensing area was miniaturized to 3 mm2 (3 mm length, 300 μm diameter) for cortical implantation while maintaining sensitivity of >2000 nm/RIU. The sensor performed consistently in vitro across diverse biological media, including blood serum, with detection limits of 1.7−2.5 μM. Upon implantation into the rat cortex, time-resolved λSPR signals were recorded over several hours after intravenous vancomycin administration, representing to our knowledge the first demonstration of plasmonic fiber-based monitoring of a small-molecule drug directly in brain tissue. Baseline-corrected shifts (ΔλSPR) captured in vivo drug dynamics, with a consistent absorption phase but with inter-animal variability in peak amplitude and clearance kinetics. This work establishes a proof-of-concept platform for continuous optical monitoring in deep tissue and highlights the potential of FO-SPR sensing for in vivo pharmacokinetic applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- BioMed X Institute, Heidelberg69120, Germany.
- N&MH-Neuroscience and Mental Health, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß88400, Germany.
- LiST-Life Sciences Technology, Danube Private University , Neustadt2700, Austria.
- FZU-Institute of Physics, Czech Academy of Sciences, Prague180 00, Czech Republic.
- School of Biological and Health Systems Engineering, Arizona State University, Tempe, Arizona85281, United States.
ORCID-Profile: Soohyun Park, Judith Schweimer, Roger Hasler, Jakub Dostalek, Heather Clark, Khulan Sergelen
Förderung
- Boehringer Ingelheim
- Ministerstvo Školství, Mládeže a Telovýchovy
- Grantová Agentura Ceské Republiky
- Österreichische Forschungsförderungsgesellschaft
- Amt der NÖ Landesregierung
- Federal Province of Tirol
- European Structural and Investment Funds
Zitieren
APA
Satapathy, P., Park, S., Pal, A., Santa, C., Koros, E., Schweimer, J., Hasler, R., Dostalek, J., Clark, H., Arban, R., Hengerer, B., & Sergelen, K. (2026). Aptagel Plasmonic Fiber Optic Biosensor for In Vivo Continuous Drug Monitoring. ACS Sensors, 11(7), 5858-5868. https://doi.org/10.1021/acssensors.6c00681
Vancouver
Satapathy P, Park S, Pal A, Santa C, Koros E, Schweimer J, et al. Aptagel Plasmonic Fiber Optic Biosensor for In Vivo Continuous Drug Monitoring. ACS Sensors. 2026;11(7):5858-5868. doi:10.1021/acssensors.6c00681
BibTeX
@article{Satapathy2026,
author = {Satapathy, Pragnya and Park, Soohyun and Pal, Anil and Santa, Catia and Koros, Eliza and Schweimer, Judith and Hasler, Roger and Dostalek, Jakub and Clark, Heather and Arban, Roberto and Hengerer, Bastian and Sergelen, Khulan},
title = {Aptagel Plasmonic Fiber Optic Biosensor for In Vivo Continuous Drug Monitoring},
journal = {ACS Sensors},
year = {2026},
volume = {11},
number = {7},
pages = {5858--5868},
doi = {10.1021/acssensors.6c00681}
}
EUVIMED